Find out more about Arjuna. Click the player below for an audio program – an interview with Dr John Douillard D.O, Ayurvedic Practitioner, on the Deborah Ray Show. Click the right facing triangle to START the audio program. To skip to the next track click the right facing double triangles. To skip to previous track click the left facing double triangles.
Ayurvedic Name: Arjuna
Botanical Name: Terminalia arjuna
Common/English Name: Arjun myrobalan
Part(s) Used: Bark
Major Constituents: Arjunic acid, Arjunin, Terminic acid, glycosides such as Arjunoside I to IV.
Other Ingredients: Capsule (plant-derived Cellulose), potato starch powder.
This product is Gluten free and vegan. Wildcrafted source material is inherently NON-GMO. Free from artificial colors, preservatives or additives.
Serving Size: 1 Capsule
Servings Per Container: 60
Amount per serving
Arjuna** (Terminalia arjuna) 60 mg*
*Daily value not established
Other ingredients: Capsule (plant-derived Cellulose), Potato starch powder.
*Wildcrafted, Gluten Free. Wildcrafted source material is inherently NON-GMO
Individulas of dominant Pitta or Kapha Doshas are susceptible to imbalances of their cardiac functions. A Pitta person is naturally ambitious and driven. When exaggerated these qualities cause imbalances, stress symptoms and inflammation. This can affect normal heart function. Kapha people are naturally laid back and are not “high energy” types. When out of balance Kapha types accumulate fat and by-products such as cholesterol which in turn can put extra workload on the heart.
Pitta people should try to reduce stress, lower caffeine intake and try Yoga. Kapha folks should start a regimented exercise program.
Both Pitta and Kapha types should reduce intake of oily, heavy foods, alcohol, when out of balance.
Clinical Research Links
Partial List of Clinical Studies and articles: (Click on the name of the study to read more at “The National Library of Medicine”)
Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation. Kapoor D, Vijayvergiya R, Dhawan V, J Ethnopharmacol. 2014 Sep 11;155(2):1029-45
Inhibitory effects of Terminalia arjuna on platelet activation in-vitro in healthy subjects and patients with coronary artery disease. Mailk N, Dhawan V, Bahl A, Kaul, D. Platelets, 2009 May; 20 (3):183-90
Terminalia arjuna protects mouse hearts against sodium flouride-induced oxidative stress. Sinha M, Manna P, Sil PC. J Med Food, 2008 Dec: 11(4): 733-40
Antigenotoxic properties of Terminalia arjuna bark extracts. Scassellati-Sforzolini G,Villarini LM, Moretti LM, Marcarelli LM, Pasquini R, Fatigoni C, Kaur LS, Kumar S, Grover IS. J Environ Pathol Toxicol Oncol.,1999;18(2):119-25.
Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Indian Heart J., 2002 Mar-Apr;54(2):170-5.
Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. J Ethnopharmacol., 2001 May;75(2-3):197-201.
Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. Dwivedi S, Agarwal MP. J Assoc Physicians India. ,1994 Apr;42(4):287-9.
Effect of oleanane triterpenoids from Terminalia arjuna–a cardioprotective drug on the process of respiratory oxyburst. Pawar RS, Bhutani KK. Phytomedicine. 2005 May;12(5):391-3.
Role of Terminalia arjuna in ischaemic mitral regurgitation Dwivedi S, Aggarwal A, Agarwal MP, Rajpal S.Int J Cardiol. 2005 Apr 28;100(3):507-8.
Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein.Gauthaman K, Banerjee SK, Dinda AK, Ghosh CC, Maulik SK. J Ethnopharmacol. 2005 Jan 15;96(3):403-9. Epub 2004 Nov 21.
Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Karthikeyan K, Bai BR, Gauthaman K, Sathish KS, Devaraj SN. Life Sci. 2003 Oct 10;73(21):2727-39.
Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, Agarwal SK, Jha S, Mukherjee R, Burman AC. J Ethnopharmacol. 2008 Apr 17;117(1):123-9. Epub 2008 Feb 3.
Medicinal properties of Terminalia arjuna (Roxb.) Wight & Arn.: A review Augustine Amalraj and Sreeraj Gopi, J Tradit Complement Med. 2017 Jan; 7(1): 65–78
Terminalia arjuna prevents Interleukin-18-induced atherosclerosis Bhat OM, Kumar PU, Rao KR, Ahmad A, Dhawan V. Inflammopharmacology. 2018 Apr;26(2):583-598. doi: 10.1007/s10787-017-0357-9. Epub 2017 May 25
Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna Kumar S, Jahangir Alam M, Prabhakar P, Ahmad S, Maulik SK, Sharma M, Goswami SK J Ethnopharmacol. 2017 Feb 23;198:98-108. doi: 10.1016/j.jep.2016.12.050. Epub 2017 Jan 4.